Cryo-Cell International Inc (NYSEAMERICAN: CCEL) suffers from extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume.
Recent significant negative changes in fundamentals have impacted Cryo-Cell International Inc (NYSEAMERICAN: CCEL): the consensus estimate for November, 2025 decreased significantly, and the consensus estimate for November, 2026 decreased significantly.
The stock is currently unrated.
Current PriceTarget Research Rating
Cryo-Cell International is currently unrated.
Recent Price Action
Cryo-Cell International Inc (NYSEAMERICAN: CCEL) stock closed at $6.50 on 3/10/25 after a large decline of -9.4%. Moreover, trading volume in this decline was exceptionally high at 358% of normal. The stock has been strong relative to the market over the last nine months but has declined -17.7% during the last week.
Be the first to comment